Your browser doesn't support javascript.
loading
A discriminant analysis of plasma metabolomics for the assessment of metabolic responsiveness to red raspberry consumption.
Barbe, Valentin; de Toro-Martín, Juan; San-Cristobal, Rodrigo; Garneau, Véronique; Pilon, Geneviève; Couture, Patrick; Roy, Denis; Couillard, Charles; Marette, André; Vohl, Marie-Claude.
Afiliação
  • Barbe V; Centre Nutrition, santé et société (NUTRISS), Université Laval, Québec City, QC, Canada.
  • de Toro-Martín J; Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec City, QC, Canada.
  • San-Cristobal R; School of Nutrition, Université Laval, Québec City, QC, Canada.
  • Garneau V; Centre Nutrition, santé et société (NUTRISS), Université Laval, Québec City, QC, Canada.
  • Pilon G; Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec City, QC, Canada.
  • Couture P; School of Nutrition, Université Laval, Québec City, QC, Canada.
  • Roy D; Centre Nutrition, santé et société (NUTRISS), Université Laval, Québec City, QC, Canada.
  • Couillard C; Institut sur la nutrition et les aliments fonctionnels (INAF), Université Laval, Québec City, QC, Canada.
  • Marette A; School of Nutrition, Université Laval, Québec City, QC, Canada.
  • Vohl MC; Centre Nutrition, santé et société (NUTRISS), Université Laval, Québec City, QC, Canada.
Front Nutr ; 10: 1104685, 2023.
Article em En | MEDLINE | ID: mdl-37125033
Background: Many studies show that the intake of raspberries is beneficial to immune-metabolic health, but the responses of individuals are heterogeneous and not fully understood. Methods: In a two-arm parallel-group, randomized, controlled trial, immune-metabolic outcomes and plasma metabolite levels were analyzed before and after an 8-week red raspberry consumption. Based on partial least squares discriminant analysis (PLS-DA) on plasma xenobiotic levels, adherence to the intervention was first evaluated. A second PLS-DA followed by hierarchical clustering was used to classify individuals into response subgroups. Clinical immune and metabolic outcomes, including insulin resistance (HOMA-IR) and sensitivity (Matsuda, QUICKI) indices, during the intervention were assessed and compared between response subgroups. Results: Two subgroups of participants, type 1 responders (n = 17) and type 2 responders (n = 5), were identified based on plasma metabolite levels measured during the intervention. Type 1 responders showed neutral to negative effects on immune-metabolic clinical parameters after raspberry consumption, and type 2 responders showed positive effects on the same parameters. Changes in waist circumference, waist-to-hip ratio, fasting plasma apolipoprotein B, C-reactive protein and insulin levels as well as Matsuda, HOMA-IR and QUICKI were significantly different between the two response subgroups. A deleterious effect of two carotenoid metabolites was also observed in type 1 responders but these variables were significantly associated with beneficial changes in the QUICKI index and in fasting insulin levels in type 2 responders. Increased 3-ureidopropionate levels were associated with a decrease in the Matsuda index in type 2 responders, suggesting that this metabolite is associated with a decrease in insulin sensitivity for those subjects, whereas the opposite was observed for type 1 responders. Conclusion: The beneficial effects associated with red raspberry consumption are subject to inter-individual variability. Metabolomics-based clustering appears to be an effective way to assess adherence to a nutritional intervention and to classify individuals according to their immune-metabolic responsiveness to the intervention. This approach may be replicated in future studies to provide a better understanding of how interindividual variability impacts the effects of nutritional interventions on immune-metabolic health.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Nutr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Idioma: En Revista: Front Nutr Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Canadá País de publicação: Suíça